T2	Participants 282 331	patients with progressive multiple sclerosis (MS)
T3	Participants 884 911	single centre (Bristol, UK)
T4	Participants 913 1085	Eighty patients with progressive MS will be recruited; 60 will have secondary progressive disease (SPMS) but a subset (n = 20) will have primary progressive disease (PPMS).
T1	Participants 54 84	progressive Multiple Sclerosis
T5	Participants 2306 2317	MS patients
T6	Participants 2122 2136	progressive MS
